## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.97 indicates fundamental undervaluation. Quality metrics strong (ROE 41%). Analyst consensus $2783 (+30% upside).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($2010.30)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Bearish (Bullish: 0, Bearish: 2)

**1. MercadoLibre stock slides into 2026 as MELI investors eye Feb. 24 earnings and a big U.S. data week**
- Source: ts2.tech | 20260105T030859 | Bearish | Relevance: 100%
- MercadoLibre (MELI) stock closed down 2.0% on Friday at $1,973.70, performing weakly at the start of 2026. Investors are closely watching upcoming U.S. economic data, including the ISM manufacturing index and the December nonfarm payrolls report, as well as MercadoLibre's Q4 2025 earnings provisionally set for February 24. Management changes, with Ariel Szarfsztejn taking over as CEO, also add to the factors influencing investor sentiment in early 2026.

**2. MercadoLibre stock (MELI) drops 2% as 2026 opens; traders eye $2,000 and next catalysts**
- Source: ts2.tech | 20260103T153700 | Bearish | Relevance: 100%
- MercadoLibre (MELI) stock opened 2026 down 2.0% at $1,973.70, with traders watching for it to reclaim the $2,000 level amidst market volatility and a recent downgrade from Zacks Research. The company, a major proxy for Latin American consumer demand and digital payments, faces pressure from rising U.S. Treasury yields, while its next major catalyst will be earnings, expected around February 19th.

**3. GAM Holding AG Buys 915 Shares of MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20260103T130853 | Neutral | Relevance: 100%
- GAM Holding AG increased its stake in MercadoLibre, Inc. by 47.5% through the acquisition of 915 shares, bringing its total holdings to 2,840 shares valued at approximately $6.64 million. Despite recent analyst price target trims, MercadoLibre maintains a "Moderate Buy" consensus rating with a target price of $2,842.94. Insider sales amounted to 1,136 shares worth $2.31 million in the last 90 days, while institutional investors hold 87.62% of the company's stock.

**4. Northcape Capital Pty Ltd Has $186.92 Million Stock Position in MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20260104T130859 | Neutral | Relevance: 98%
- Northcape Capital Pty Ltd decreased its stake in MercadoLibre (NASDAQ:MELI) by 2.5% in Q3, holding 79,986 shares valued at $186.92 million, making it their second-largest holding at 25.8% of their portfolio. Despite an EPS miss, MercadoLibre's revenue beat expectations, with analysts maintaining a "Moderate Buy" rating and an average price target of $2,842.94. Insiders have sold shares worth approximately $2.31 million in the last three months, though they still own 0.25% of the company.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wedbush | $2700 | $2800 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wedbush | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($2.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 5.3% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +7.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.97 indicates undervaluation relative to growth. Forward P/E 35.9x attractive for 49% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $108.9B |
| Beta | 1.42 |
| 52W Range | $1723.90 - $2645.22 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.97 |
| Forward P/E | 35.9 |
| Current P/E | 53.6 |
| YoY Growth | 49.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -0.8% to 6.8% (+7.6% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 5.4% confirms short-term momentum alignment. AM_20 at 7.0% shows strong absolute momentum above own 20MA. Outperforming sector by 7.1pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (15.73), confirming momentum. OFD pattern: +MUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.81% (CS: 92) | Strong |
| RSI_14 | 62.0 | Neutral |
| MACD Histogram | 15.73 | Bullish |
| vs SMA20 | 1.070x | Above |
| vs SMA50 | 1.031x | Above |
| vs SMA200 | 0.947x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $2148.62
- **Stop Loss:** $2010.30 (6.4% risk)
- **Target:** $2425.26 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 8
- **Position Value:** $17,188.96
- **Portfolio %:** 17.19%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*